Cannabis, Autism, MS and ALS.


Zach Klien has worked with parents of an 11 year old Autistic boy who was unresponsive to medication and simultaneously suffered from the side effects of those medications. The parents described their lives as ‘a living hell’, said Klein. They acquired a license to use medical Cannabis on their son, and over time increased the child’s dosage to 7.5 mg of THC throughout each day. After a month of treatment the child showed no signs of agitation or aggression. His sleep, communication and moods improved. After 3 months he was able to return to school.

MS and ALS

A 1997 House of Lords Report found that too many Multiple Sclerosis sufferers were being arrested for Cannabis possession. The report sparked research by GW pharmaceuticals that led to the development of Sativex – a Cannabis alcohol medication. This medication is now sold in 12 states globally and has passed Australia’s Therapeutic Goods Administration (TGA).

Amytrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that effects nerve cells in the brain and spinal cord.

At the Symposium the following condition were mentioned – either for Cannabis’ ability to treat the symptoms or pain relief:

  • Restless leg syndrome – Restless leg syndrome is a neurological disorder. Sufferers experience strange uncomfortable sensations in their legs and the desire to move them.

  • Complex Reflex Sympathetic Dystrophy – Complex Reflex Sympathetic Dystrophy is a chronic neurological syndrome where sufferers experience severe burning pain, excessive sweating and tissue swelling.

  • Chrones disease – Chrones disease causes ulcers and fistulae in the intestines. Cannabis’s anti-inflammatory effects can be used to help sufferers.

  • Irritable Bowel Syndrome – Irritable Bowel Syndrome causes abdominal paid coupled with either diarrhoea or constipation.

  • Cyclical Vomiting Syndrome – Sufferers from CVM endure alternating cycles of severe vomiting and non-vomiting periods that can last for hours or days.

Members of law enforcement were also present at the Symposium sharing their perspective which will be covered in next weeks blog.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>